United States Food and Drug Administration (USFDA) has completed inspection at Ajanta Pharma’s Dahej formulation facility. At the end of inspection, USFDA issued no Form 483 to the said facility. The formulation facility at Dahej was inspected by US FDA from June 19, 2023 to June 23, 2023.
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.